Serial Number 98649589
688

Registration Progress

Application Filed
Jul 15, 2024
Under Examination
Jul 8, 2025
Approved for Publication
May 13, 2025
Published for Opposition
May 13, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jan 08, 2026 171 days

Trademark Image

Basic Information

Serial Number
98649589
Filing Date
July 15, 2024
Published for Opposition
May 13, 2025
Drawing Code
2

Status Summary

Current Status
Active
Status Code
688
Status Date
Jul 8, 2025
Application
Pending
Classes
001 005 042

Rights Holder

Oruka Therapeutics, Inc.

03
Address
855 Oak Grove Ave., Suite 100
Menlo Park, CA 94025

Ownership History

Oruka Therapeutics, Inc.

Original Applicant
03
Menlo Park, CA

Oruka Therapeutics, Inc.

Owner at Publication
03
Menlo Park, CA

Legal Representation

Attorney
Nichole T. Hayden

USPTO Deadlines

Next Deadline
171 days remaining
NOA E-Mailed - SOU Required
Due Date
January 08, 2026
Extension Available
Until July 08, 2026

Application History

15 events
Date Code Type Description Documents
Jul 8, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 13, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 13, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 7, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 16, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 26, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 26, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 26, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 10, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 10, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 10, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 6, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 5, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 5, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 15, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Biochemical preparations for scientific purposes, namely, in vitro scientific or research use; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
Class 005
Biologics in the nature of pharmaceutical preparations for treatment of chronic skin diseases, namely, plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications; Antibodies for medical purposes, namely, for treatment of chronic skin diseases, namely, plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications; Therapeutic pharmaceutical for the treatment of chronic skin diseases such as plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications
Class 042
Biotechnology research related to antibodies and therapies for treatment of chronic skin diseases such as plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications

Additional Information

Design Mark
The mark consists of curved waves in a circular pattern.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
001 005 042